Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
February 21, 2025 | Uncategorized
Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortage
Comments
Related Posts
-
Tencent becomes a Linux Foundation platinum member to increase its focus on open source
-
How vacant spaces are becoming pop up opportunities for landlords, retailers
-
Technological solutions to technology’s problems feature in “How to Fix The Future”
-
#microsoft says employees will be expected in office three days a week